OSCR Oscar Health, Inc.
Healthcare$21.89-3.31%ClosedMarket Cap: $5.68B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.06
P/S
0.44
EV/EBITDA
77.77
DCF Value
$-124.98
FCF Yield
47.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
17.4%
Operating Margin
0.1%
Net Margin
-0.3%
ROE
-3.3%
ROA
-0.4%
ROIC
0.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $4.65B | 30.5% | $704.1M | $679.0M | $— | — |
| Q4 null | $2.81B | 6.6% | $-333.7M | $-352.6M | $— | — |
| FY null | $11.70B | 14.4% | $-396.4M | $-443.2M | $— | — |
| Q3 null | $2.99B | 13.4% | $-129.3M | $-137.4M | $— | — |
| Q2 null | $2.86B | 10.9% | $-230.5M | $-228.4M | $— | — |
| Q1 null | $3.05B | 25.8% | $297.1M | $275.3M | $— | — |
| Q4 null | $2.39B | 13.7% | $-147.7M | $-153.5M | $— | — |
| FY null | $9.18B | 20.1% | $57.3M | $25.4M | $— | — |
| Q3 null | $2.42B | 100.0% | $-52.3M | $-54.6M | $— | — |
| Q2 null | $2.22B | 100.0% | $60.9M | $56.2M | $— | — |
| Q1 null | $2.14B | 100.0% | $178.5M | $177.4M | $— | — |
| Q4 2023 | $1.43B | 100.0% | $-150.6M | $-150.0M | $-0.66 | — |